1068 related articles for article (PubMed ID: 17596302)
21. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
22. Effect of DNA synthesis inhibitors on Kaposi's sarcoma-associated herpesvirus cyclin and major capsid protein gene expression.
Flore O; Gao SJ
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1229-33. PubMed ID: 9310290
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
[TBL] [Abstract][Full Text] [Related]
24. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
26. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
Xu Y; AuCoin DP; Huete AR; Cei SA; Hanson LJ; Pari GS
J Virol; 2005 Mar; 79(6):3479-87. PubMed ID: 15731242
[TBL] [Abstract][Full Text] [Related]
27. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
Zhang L; Chiu J; Lin JC
DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.
Lukac DM; Kirshner JR; Ganem D
J Virol; 1999 Nov; 73(11):9348-61. PubMed ID: 10516043
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
30. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
[TBL] [Abstract][Full Text] [Related]
31. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
Hui KF; Chiang AK
Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
[TBL] [Abstract][Full Text] [Related]
32. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.
Chang LK; Liu ST
Nucleic Acids Res; 2000 Oct; 28(20):3918-25. PubMed ID: 11024171
[TBL] [Abstract][Full Text] [Related]
33. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines.
Gao X; Tajima M; Sairenji T
Virology; 1999 Jun; 258(2):375-81. PubMed ID: 10366574
[TBL] [Abstract][Full Text] [Related]
35. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.
Gradoville L; Gerlach J; Grogan E; Shedd D; Nikiforow S; Metroka C; Miller G
J Virol; 2000 Jul; 74(13):6207-12. PubMed ID: 10846108
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
38. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
[TBL] [Abstract][Full Text] [Related]
39. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.
Wu TT; Usherwood EJ; Stewart JP; Nash AA; Sun R
J Virol; 2000 Apr; 74(8):3659-67. PubMed ID: 10729142
[TBL] [Abstract][Full Text] [Related]
40. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
